These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11860349)

  • 21. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?
    Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):929-31. PubMed ID: 15042326
    [No Abstract]   [Full Text] [Related]  

  • 23. Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.
    Aranda E; Aparicio J; Bilbao JI; García-Alfonso P; Maurel J; Rodríguez J; Sangro B; Vieitez JM; Feliu J
    Future Oncol; 2017 Oct; 13(23):2065-2082. PubMed ID: 28703622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.
    Lee EW; Alanis L; Cho SK; Saab S
    Korean J Radiol; 2016; 17(4):472-88. PubMed ID: 27390539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-cancer radiopharmaceuticals.
    Hoefnagel CA
    Anticancer Drugs; 1991 Apr; 2(2):107-32. PubMed ID: 1958857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
    Garin E; Rolland Y; Laffont S; Edeline J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer.
    Yan ZP; Lin G; Zhao HY; Dong YH
    Cancer; 1993 Dec; 72(11):3210-5. PubMed ID: 8242543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
    Hamoudeh M; Kamleh MA; Diab R; Fessi H
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1329-46. PubMed ID: 18562040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
    Allison C
    Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear localizing sequences: an innovative way to improve targeted radiotherapy.
    O'Donnell RT
    J Nucl Med; 2006 May; 47(5):738-9. PubMed ID: 16644741
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
    Häfeli UO; Casillas S; Dietz DW; Pauer GJ; Rybicki LA; Conzone SD; Day DE
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):189-99. PubMed ID: 10219814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
    Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
    J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?
    Gates VL; Hickey R; Marshall K; Williams M; Salzig K; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2038-44. PubMed ID: 26194715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
    van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
    J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
    Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.